Flatiron

News

A pair of spectacles in front of computer screens

Does Roche have buyer's remorse for Flatiron takeover?

Roche is reported to be considering the sale of its cancer data specialist Flatiron Health, just a few years after it bought the company for $1.9 billion.

News

BMS strikes three-year cancer R&D deal with Flatiron

Bristol-Myers Squibb has struck a three-year with Flatiron Health that aims to make cancer R&D more efficient and patient-focused.

News

Pfizer might buy BMS for $130bn – but should it?

Pfizer could soon launch a multi-billion dollar bid for immunotherapy rivals Bristol-Myers Squibb.

Does Roche have buyer's remorse for Flatiron takeover?

BMS strikes three-year cancer R&D deal with Flatiron

Pfizer might buy BMS for $130bn – but should it?

Scribe Therapeutics joins the IPO queue

Discover a new era of healthcare panel engagement: Grounded ...

Editor's Picks